Sofinnova Investments, Inc. Ikena Oncology, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.23 Billion
- Q4 2024
A detailed history of Sofinnova Investments, Inc. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 382,616 shares of IKNA stock, worth $451,486. This represents 0.05% of its overall portfolio holdings.
Number of Shares
382,616
Previous 382,616
-0.0%
Holding current value
$451,486
Previous $661,000
5.14%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
52Shares Held
31.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$5.92 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$4.83 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$4.73 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.71MShares$4.38 Million3.84% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.18 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $42.8M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...